312 related articles for article (PubMed ID: 32665030)
1. Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia.
Monard C; Pehlivan J; Auger G; Alviset S; Tran Dinh A; Duquaire P; Gastli N; d'Humières C; Maamar A; Boibieux A; Baldeyrou M; Loubinoux J; Dauwalder O; Cattoir V; Armand-Lefèvre L; Kernéis S;
Crit Care; 2020 Jul; 24(1):434. PubMed ID: 32665030
[TBL] [Abstract][Full Text] [Related]
2. Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR).
Serigstad S; Ritz C; Faurholt-Jepsen D; Markussen D; Ebbesen MH; Kommedal Ø; Bjørneklett RO; Heggelund L; Clark TW; van Werkhoven CH; Knoop ST; Ulvestad E; Grewal HMS;
Trials; 2022 Aug; 23(1):622. PubMed ID: 35915452
[TBL] [Abstract][Full Text] [Related]
3. Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia.
Peiffer-Smadja N; Bouadma L; Mathy V; Allouche K; Patrier J; Reboul M; Montravers P; Timsit JF; Armand-Lefevre L
Crit Care; 2020 Jun; 24(1):366. PubMed ID: 32560662
[TBL] [Abstract][Full Text] [Related]
4. Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit.
Maataoui N; Chemali L; Patrier J; Tran Dinh A; Le Fèvre L; Lortat-Jacob B; Marzouk M; d'Humières C; Rondinaud E; Ruppé E; Montravers P; Timsit JF; Armand-Lefèvre L
Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2227-2234. PubMed ID: 33733394
[TBL] [Abstract][Full Text] [Related]
5. INHALE: the impact of using FilmArray Pneumonia Panel molecular diagnostics for hospital-acquired and ventilator-associated pneumonia on antimicrobial stewardship and patient outcomes in UK Critical Care-study protocol for a multicentre randomised controlled trial.
High J; Enne VI; Barber JA; Brealey D; Turner DA; Horne R; Peters M; Dhesi Z; Wagner AP; Pandolfo AM; Stirling S; Russell C; O'Grady J; Swart AM; Gant V; Livermore DM;
Trials; 2021 Oct; 22(1):680. PubMed ID: 34620213
[TBL] [Abstract][Full Text] [Related]
6. Multicentre evaluation of two multiplex PCR platforms for the rapid microbiological investigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study.
Enne VI; Aydin A; Baldan R; Owen DR; Richardson H; Ricciardi F; Russell C; Nomamiukor-Ikeji BO; Swart AM; High J; Colles A; Barber J; Gant V; Livermore DM; O'Grady J;
Thorax; 2022 Dec; 77(12):1220-1228. PubMed ID: 35027473
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital's Five-Month Experience.
Posteraro B; Cortazzo V; Liotti FM; Menchinelli G; Ippoliti C; De Angelis G; La Sorda M; Capalbo G; Vargas J; Antonelli M; Sanguinetti M; De Pascale G; Spanu T
Microbiol Spectr; 2021 Dec; 9(3):e0069521. PubMed ID: 34756067
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of point-of-care multiplex PCR to rapidly identify pathogens responsible for ventilator-associated pneumonia and their resistance to antibiotics: an observational study.
Luyt CE; Hékimian G; Bonnet I; Bréchot N; Schmidt M; Robert J; Combes A; Aubry A
Crit Care; 2020 Jun; 24(1):378. PubMed ID: 32586347
[TBL] [Abstract][Full Text] [Related]
9. Development of antibiotic treatment algorithms based on local ecology and respiratory surveillance cultures to restrict the use of broad-spectrum antimicrobial drugs in the treatment of hospital-acquired pneumonia in the intensive care unit: a retrospective analysis.
De Bus L; Saerens L; Gadeyne B; Boelens J; Claeys G; De Waele JJ; Benoit DD; Decruyenaere J; Depuydt PO
Crit Care; 2014 Jul; 18(4):R152. PubMed ID: 25030270
[TBL] [Abstract][Full Text] [Related]
10. Potential Impact of Rapid Multiplex PCR on Antimicrobial Therapy Guidance for Ventilated Hospital-Acquired Pneumonia in Critically Ill Patients, A Prospective Observational Clinical and Economic Study.
Guillotin F; Poulain C; Gaborit B; Bouras M; Cinotti R; Lakhal K; Vourc'h M; Rozec B; Asehnoune K; Vibet MA; Riche VP; Gibaud SA; Crémet L; Roquilly A
Front Cell Infect Microbiol; 2022; 12():804611. PubMed ID: 35493730
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic concordance between BioFire® FilmArray® Pneumonia Panel and culture in patients with COVID-19 pneumonia admitted to intensive care units: the experience of the third wave in eight hospitals in Colombia.
Molina FJ; Botero LE; Isaza JP; Cano LE; López L; Tamayo L; Torres A
Crit Care; 2022 May; 26(1):130. PubMed ID: 35534867
[TBL] [Abstract][Full Text] [Related]
12. Performance of PCR-based syndromic testing compared to bacterial culture in patients with suspected pneumonia applying microscopy for quality assessment.
Andrews V; Pinholt M; Schneider UV; Schønning K; Søes LM; Lisby G
APMIS; 2022 Jul; 130(7):417-426. PubMed ID: 35499302
[TBL] [Abstract][Full Text] [Related]
13. Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units.
Voiriot G; Fartoukh M; Durand-Zaleski I; Berard L; Rousseau A; Armand-Lefevre L; Verdet C; Argaud L; Klouche K; Megarbane B; Patrier J; Richard JC; Reignier J; Schwebel C; Souweine B; Tandjaoui-Lambiotte Y; Simon T; Timsit JF;
BMJ Open; 2021 Aug; 11(8):e048187. PubMed ID: 34408046
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial therapy of community-acquired pneumonia during stewardship efforts and a coronavirus pandemic: an observational study.
Waagsbø B; Tranung M; Damås JK; Heggelund L
BMC Pulm Med; 2022 Oct; 22(1):379. PubMed ID: 36242006
[TBL] [Abstract][Full Text] [Related]
15. Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use.
Andrews D; Chetty Y; Cooper BS; Virk M; Glass SK; Letters A; Kelly PA; Sudhanva M; Jeyaratnam D
BMC Infect Dis; 2017 Oct; 17(1):671. PubMed ID: 29017451
[TBL] [Abstract][Full Text] [Related]
16. Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units.
Lee SH; Ruan SY; Pan SC; Lee TF; Chien JY; Hsueh PR
J Microbiol Immunol Infect; 2019 Dec; 52(6):920-928. PubMed ID: 31806539
[TBL] [Abstract][Full Text] [Related]
17. Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP).
Deshpande A; Walker R; Schulte R; Pallotta AM; Tereshchenko LG; Hu B; Kadri SS; Klompas M; Rothberg MB
Trials; 2023 Sep; 24(1):595. PubMed ID: 37716990
[TBL] [Abstract][Full Text] [Related]
18. Performance of the extended use of the FilmArray
Sansot M; Fradin E; Chenouard R; Kempf M; Kouatchet A; Lasocki S; Lemarié C; Eveillard M; Pailhoriès H
Mol Biol Rep; 2019 Jun; 46(3):2685-2692. PubMed ID: 30798486
[TBL] [Abstract][Full Text] [Related]
19. Application of a multiplex molecular pneumonia panel and real-world impact on antimicrobial stewardship among patients with hospital-acquired and ventilator-associated pneumonia in intensive care units.
Chen CL; Tseng HY; Chen WC; Liang SJ; Tu CY; Lin YC; Hsueh PR
J Microbiol Immunol Infect; 2024 Jun; 57(3):480-489. PubMed ID: 38471985
[TBL] [Abstract][Full Text] [Related]
20. Rapid syndromic molecular testing in pneumonia: The current landscape and future potential.
Poole S; Clark TW
J Infect; 2020 Jan; 80(1):1-7. PubMed ID: 31809764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
